These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34126086)

  • 1. Chronic histiocytic intervillositis: manifestation of placental alloantibody-mediated rejection.
    Benachi A; Rabant M; Martinovic J; Bouchghoul H; Vivanti AJ; Leon J; Grunenwald A; Roumenina L; Celton JL; Bessieres B; Taupin JL; Zuber J
    Am J Obstet Gynecol; 2021 Dec; 225(6):662.e1-662.e11. PubMed ID: 34126086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C4d Staining Is Present in Normal Placentas From Pregnancies Prior to Pregnancy Loss Associated With Chronic Histiocytic Intervillositis and Is Reduced by Immunomodulatory Therapy in Subsequent Pregnancies.
    Chan ES; de Koning L; Yu W; Chadha R
    Pediatr Dev Pathol; 2023; 26(4):374-387. PubMed ID: 37232363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement receptor-associated CD163
    Hussein K; Stucki-Koch A; Müller AM; Arnold R; Kreipe H; Feist H
    Placenta; 2019 Mar; 78():23-28. PubMed ID: 30955707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of C4d Immunostaining in Placental Chronic Intervillositis.
    Bendon RW; Coventry S; Thompson M; Rudzinski ER; Williams EM; Oron AP
    Pediatr Dev Pathol; 2015; 18(5):362-8. PubMed ID: 25970733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Chronic Intervillositis: The Diagnostic Challenge - A Case Report and Review of the Literature.
    Hannaford P; Mittal N; Sethna F; Dahlstrom JE
    J Obstet Gynaecol Can; 2019 Mar; 41(3):344-347. PubMed ID: 30414807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.
    Cornish EF; McDonnell T; Williams DJ
    Front Immunol; 2022; 13():825075. PubMed ID: 35529853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39 downregulation in chronic intervillositis of unknown etiology.
    Sato Y; Maekawa K; Aman M; Yamashita A; Kodama Y; Maki Y; Sameshima H; Asada Y
    Virchows Arch; 2019 Sep; 475(3):357-364. PubMed ID: 31218404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review.
    Bos M; Nikkels PGJ; Cohen D; Schoones JW; Bloemenkamp KWM; Bruijn JA; Baelde HJ; van der Hoorn MLP; Turner RJ
    Placenta; 2018 Jan; 61():80-88. PubMed ID: 29277275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent chronic histiocytic intervillositis with intrauterine growth restriction, osteopenia, and fractures.
    Crawford A; Moore L; Bennett G; Savarirayan R; Manton N; Khong Y; Barnett CP; Haan E
    Am J Med Genet A; 2016 Nov; 170(11):2960-2964. PubMed ID: 27481052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual crossmatching reveals upregulation of placental HLA-Class II in chronic histiocytic intervillositis.
    Brady CA; Ford LB; Moss C; Zou Z; Crocker IP; Heazell AEP
    Sci Rep; 2024 Aug; 14(1):18714. PubMed ID: 39134702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic histiocytic intervillositis with cytomegalovirus placentitis in a case of hydrops fetalis.
    Taweevisit M; Sukpan K; Siriaunkgul S; Thorner PS
    Fetal Pediatr Pathol; 2012 Dec; 31(6):394-400. PubMed ID: 22443234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular adhesion molecule-1 expression in massive chronic intervillositis: implications for the invasion of maternal cells into fetal tissues.
    Labarrere CA; Bammerlin E; Hardin JW; Dicarlo HL
    Placenta; 2014 May; 35(5):311-7. PubMed ID: 24631282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178 cases.
    Nowak C; Joubert M; Jossic F; Masseau A; Hamidou M; Philippe HJ; Le Vaillant C
    Placenta; 2016 Aug; 44():104-8. PubMed ID: 27452445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].
    Feist H; Blöcker T; Hussein K
    Pathologe; 2015 Jul; 36(4):355-61. PubMed ID: 25613921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in chronic intervillositis of unknown etiology.
    Bos M; Harris-Mostert ETMS; van der Meeren LE; Baelde JJ; Williams DJ; Nikkels PGJ; Bloemenkamp KWM; van der Hoorn MLP
    Placenta; 2020 Feb; 91():19-23. PubMed ID: 32174302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases.
    Marchaudon V; Devisme L; Petit S; Ansart-Franquet H; Vaast P; Subtil D
    Placenta; 2011 Feb; 32(2):140-5. PubMed ID: 21183219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report.
    Weber MA; Nikkels PG; Hamoen K; Duvekot JJ; de Krijger RR
    Pediatr Dev Pathol; 2006; 9(3):234-8. PubMed ID: 16944973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Histiocytic Intervillositis With Trophoblast Necrosis Is a Risk Factor Associated With Placental Infection From Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Live-Born and Stillborn Infants.
    Schwartz DA; Baldewijns M; Benachi A; Bugatti M; Collins RRJ; De Luca D; Facchetti F; Linn RL; Marcelis L; Morotti D; Morotti R; Parks WT; Patanè L; Prevot S; Pulinx B; Rajaram V; Strybol D; Thomas K; Vivanti AJ
    Arch Pathol Lab Med; 2021 May; 145(5):517-528. PubMed ID: 33393592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?
    Brady CA; Williams C; Sharps MC; Shelleh A; Batra G; Heazell AEP; Crocker IP
    Am J Reprod Immunol; 2021 Mar; 85(3):e13373. PubMed ID: 33155353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.
    Abisror N; Cheloufi M; Cohen J; Coulomb A; McAvoy C; Fain O; Taupin JL; Tsatsaris V; Kayem G; Mekinian A
    Am J Reprod Immunol; 2024 Jul; 92(1):e13898. PubMed ID: 38973779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.